Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
03/2010
03/30/2010US7687476 administering 4-thiouridine, isomaltitol and uridine as antiinflammatory agents and/or problems in hemostasis related to platelet function
03/30/2010US7687460 Transgenic bacteria host cell can be used for screening antibiotics , herbicides; genetic engineering; therapy for bone disorders; antiarthritic agents
03/30/2010CA2495537C Immunoregulatory compounds and derivatives and methods of treating diseases therewith
03/30/2010CA2472237C Multi-stage oral drug controlled-release system
03/30/2010CA2442245C 4,5-dihydro-1h-pyrazole derivatives having potent cb1-antagonistic activity
03/30/2010CA2436667C Novel bioactive substance
03/30/2010CA2386807C Method of preparing cox-2 inhibitors
03/30/2010CA2374755C Mono- and disubstituted 3-propyl gamma-aminobutyric acids
03/30/2010CA2362277C Spontaneously dispersible n-benzoyl staurosporine compositions
03/30/2010CA2355860C Dosage forms comprising porous particles
03/25/2010WO2010034011A2 Phenylthiophenyldihydrobenzothiazepine inhibitors of store operated calcium release
03/25/2010WO2010034003A2 Benzylthiotetrazole inhibitors of store operated calcium release
03/25/2010WO2010033980A2 4-azaindole bisphosphonates
03/25/2010WO2010033978A2 IMIDAZO[1,2-α ]PYRIDINYL BISPHOSPHONATES
03/25/2010WO2010033958A1 Nuclear factor kappa b pathway inhibitor composition and use of same
03/25/2010WO2010033941A1 Substituted imidazo[1,2b]pyridazine compounds as trk kinase inhibitors
03/25/2010WO2010033726A2 Drug delivery composition comprising a self-assembled gelator
03/25/2010WO2010033560A2 Sur1 inhibitors for therapy
03/25/2010WO2010033540A1 Crystalline forms of fentanyl alkaloid
03/25/2010WO2010033509A2 14-hydroxy-docosahexaenoic acid compounds
03/25/2010WO2010033393A1 Substituted 3 -amin0- 1-0x0 or thioxo-i, 2,5,6,7, 8-hexahydr0-2, 7-naphthyridine-4-carb0nitriles as selective alpha 2b antagonists
03/25/2010WO2010033392A2 Methods and kits for treating cluster headache disorders
03/25/2010WO2010032771A1 Amino acid derivative
03/25/2010WO2010032269A2 Anti-inflammatory activity of the iridoid glycosides
03/25/2010WO2010032010A1 Aryl-phenyl-sulfonamide-phenylene compounds and their use
03/25/2010WO2010032009A1 Aryl-phenyl-sulfonamido-cycloalkyl compounds and their use
03/25/2010WO2010031835A2 2-aryl-propionic acids and derivatives and pharmaceutical compositions containing them
03/25/2010WO2010031791A1 New compounds ii
03/25/2010WO2010031789A1 New compounds i
03/25/2010WO2010011117A3 Ndga-containing composition for the suppression of transglutaminase
03/25/2010WO2010010346A3 Topical compositions for use during tooth eruption
03/25/2010WO2010008777A3 Fused azabicyclic pyridines
03/25/2010WO2010006123A3 19-nor-vitamin d analogs with 1,2-dihydrofuran ring
03/25/2010WO2010006121A3 19-nor-vitamin d analogs with 3,2-dihydrofuran ring
03/25/2010WO2009154741A8 Thiophene or thiazole derivatives and their use as pi3k inhibitors
03/25/2010WO2009141533A3 Pyrrole derivatives, preparation of same and therapeutic application thereof as cannabinoid cb1 receptor antagonists
03/25/2010US20100076072 Compositions and methods of vitamin e administration
03/25/2010US20100076058 Methods for identifying analgesic agents
03/25/2010US20100076036 Heterocyclyl-substituted sulfonamides for the treatment of cognitive or food ingestion related disorders
03/25/2010US20100076024 Novel Compounds as Serine Protease Inhibitors
03/25/2010US20100076015 Aminopyridine Derivatives
03/25/2010US20100076014 MODULATORS OF GLUCOCORTICOID RECEPTOR, AP-1, AND/OR NF-kB ACTIVITY AND USE THEREOF
03/25/2010US20100075986 Oxophenyl-Cyclohexyl-Propanolamine Derivatives, Production And Use Thereof In Therapeutics
03/25/2010US20100075978 Sulfonamide derivatives as bradykinin antagonists
03/25/2010US20100075968 Imidazolidine Carboxamide Derivatives as P2X7 Modulators
03/25/2010US20100075961 MODULATORS OF GLUCOCORTICOID RECEPTOR, AP-1, AND/OR NF-kB ACTIVITY AND USE THEREOF
03/25/2010US20100075931 Substituted oxazole ketone modulators of fatty acid amide hydrolase
03/25/2010US20100075923 Method of enhancing tgf-beta signalling
03/25/2010US20100075910 Synthetic peptide amides and dimeric forms thereof
03/25/2010US20100074943 Medicinal composition for transdermal absorption, medicinal composition storing unit and transdermal absorption preparation using the same
03/25/2010US20100074871 Probiotic infant products
03/25/2010CA2738026A1 Substituted imidazo[1,2b]pyridazine compounds as trk kinase inhibitors
03/25/2010CA2737805A1 Probiotic infant products
03/25/2010CA2737655A1 Probiotic infant products
03/25/2010CA2737604A1 Substituted 3-amin0-1-0x0 or thioxo-1,2,5,6,7,8-hexahydr0-2,7-naphthyridine-4-carb0nitriles as selective alpha 2b antagonists
03/25/2010CA2737527A1 New compounds i
03/25/2010CA2737431A1 Amino acid derivative
03/25/2010CA2737212A1 Dendritic cell modulatory molecule
03/25/2010CA2737199A1 Novel compounds as cannabinoid receptor ligands
03/25/2010CA2737135A1 Methods and kits for treating cluster headache disorders
03/25/2010CA2737099A1 2-aryl-propionic acids and derivatives and pharmaceutical compositions containing them
03/25/2010CA2736980A1 Aryl-phenyl-sulfonamide-phenylene compounds and their use
03/25/2010CA2736971A1 Aryl-phenyl-sulfonamido-cycloalkyl compounds and their use
03/24/2010EP2166095A2 Antisense oligonucleotides capable of inhibiting the formation of capillary tubes in endothelial cells
03/24/2010EP2166087A2 FAD4, FAD5, FAD5-2 et FAD6, fatty acid desaturase family members and uses thereof
03/24/2010EP2166010A1 Pyrazolo pyridine derivatives as NADPH oxidase inhibitors
03/24/2010EP2166008A1 Pyrazolo pyridine derivatives as NADPH oxidase inhibitors
03/24/2010EP2166006A1 2-aryl-propionic acids and derivatives and pharmaceutical compositions containing them
03/24/2010EP2166003A1 Excitatory amino acid receptor antagonists
03/24/2010EP2165605A1 Use of a ribonuclease of the T2 family having actin-binding activity for inhibiting and/or reversing proliferation
03/24/2010EP2164500A1 The use of zeburaline for the treatment of autoimmune diseases or immune rejection of transplants
03/24/2010EP2164490A1 Pyrazolyl derivatives with analgesic activity and therefore useful in the treatment or prophylaxis of pain.
03/24/2010EP2164476A1 Topical composition for treating pain
03/24/2010EP1615699B1 Benzoxazinyl-amidocyclopentyl-heterocyclic modulators of chemokine receptors
03/24/2010EP1389110B1 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same
03/24/2010EP1075496B1 Binding molecules derived from immunoglobulins which do not trigger complement mediated lysis
03/24/2010CN101679988A Fusion proteins binding to growth factors
03/24/2010CN101679470A Method for production of sugar oxazoline derivative
03/24/2010CN101679447A pyrimidodiazepinone derivative
03/24/2010CN101679432A Heteroaryl compounds, compositions thereof, and use thereof as protein kinase inhibitors
03/24/2010CN101679417A New 4,8-diphenyl-polyazanaphthalene derivatives
03/24/2010CN101679413A New 3-([1,2,4]triazolo[4,3-a]pyridin-7-yl)benzamide derivatives
03/24/2010CN101679375A 8-oxy-quinoline derivatives as bradykinin b2 receptor modulators
03/24/2010CN101679361A Certain substituted amides, method of making, and method of use thereof
03/24/2010CN101679355A benzimidazole cannabinoid agonists
03/24/2010CN101679350A Quinoline derivatives for the treatment of inflammatory diseases
03/24/2010CN101679314A Compound that is a dual inhibitor of enzymes PDE7 and/or PDE4, pharmaceutical compositions and uses thereof
03/24/2010CN101679311A quinazoline compounds
03/24/2010CN101679310A Alkynylpyrimidines as Tie2 kinase inhibitors
03/24/2010CN101679291A Imidazolidine carboxamide derivatives as P2X7 modulators
03/24/2010CN101679288A Indazoles used to treat estrogen receptor beta mediated disorders
03/24/2010CN101679272A Triazolo [1, 5-a] quinolines as adenosine A3 receptor ligands
03/24/2010CN101679255A Piperidinones useful in the treatment of inflammation
03/24/2010CN101679254A Piperidinones useful in the treatment of inflammation
03/24/2010CN101679235A Azetidine derivatives and their use as prostaglandin E2 antagonists
03/24/2010CN101678108A Anti-inflammatory compositions comprising tetracyclines and use thereof in therapy
03/24/2010CN101678077A Novel antiphlogistic-analgesic agent
03/24/2010CN101678059A New use for cannabinoid-containing plant extracts
03/24/2010CN101678053A Method for treating or preventing systemic inflammation
03/24/2010CN101678032A compositions and methods for modulating inflammation using fluoroquinolones
1 ... 369 370 371 372 373 374 375 376 377 378 379 380 381 382 383 384 385 386 387 388 389 ... 1272